Lyme Disease Test Accuracy: Timing, Limitations, and Clinical Diagnosis

A negative Lyme test does not always rule out infection
Timing matters—especially early in illness
Clinical context remains essential

Lyme disease test accuracy is often misunderstood. Many patients assume that a negative Lyme disease test rules out infection. In reality, accuracy depends heavily on timing, and current laboratory tests have important limitations—especially early in infection.

Most Lyme disease testing relies on detecting antibodies produced by the immune system in response to the bacterium Borrelia burgdorferi. Because antibodies take time to develop, testing performed too early may produce false-negative results.

Testing limitations—especially early false-negative results—are a major contributor to delayed Lyme disease diagnosis.

Laboratory testing should always be interpreted alongside symptoms, exposure risk, clinical findings, and the timing of illness rather than used in isolation.

The broader clinical and diagnostic challenges surrounding Lyme disease are explored in Why Lyme Disease Tests the Limits of Medicine.

How to Interpret Lyme Disease Test Results

Laboratory tests for Lyme disease must be interpreted within the clinical context.

A negative test does not always rule out infection, particularly early in the illness.

• Negative test with symptoms: Early infection may produce false-negative results because detectable antibodies have not yet developed.
• Positive test: Results should be interpreted alongside symptoms and exposure history because antibodies may remain detectable long after infection and treatment.
• Equivocal or indeterminate result: The initial result is not clearly positive or negative. The appropriate next step depends on the assay, the complete two-tier testing result, symptoms, and timing.

Symptom patterns discussed in the Lyme Disease Symptoms Guide may help clinicians evaluate suspected infection when laboratory confirmation is incomplete.

Standard and Modified Two-Tier Lyme Testing

The CDC-recommended testing strategy uses a two-step process. Both steps may be performed using the same blood sample.

In standard two-tier testing, the first step is an enzyme immunoassay (EIA). If that result is positive or equivocal, an immunoblot is performed as the second step.

Modified two-tier testing uses a second EIA instead of an immunoblot. FDA-cleared modified two-tier algorithms are now an accepted alternative to the traditional testing approach.²

Two-tier testing improves specificity and reduces false-positive results. However, sensitivity remains lower during early infection when the antibody response is still developing.

Why Early Lyme Tests May Be Negative

Antibodies against Borrelia burgdorferi may take several weeks to become detectable.

During this early window period, patients may have symptoms but still test negative. A negative antibody test obtained soon after infection therefore does not necessarily exclude Lyme disease.

For a full discussion of early false-negative testing, see Early Lyme Disease Tests Can Be Negative.

False-Negative Lyme Disease Tests

False-negative Lyme disease tests can occur for several reasons:

• Testing performed too early in infection
• An antibody response that has not yet reached detectable levels
• Differences in individual immune responses
• Technical limitations of current assays

Diagnosing tick-borne diseases can be challenging because infections may present with overlapping symptoms and require different testing approaches depending on the pathogen and stage of illness.

Because of these limitations, test results should not be interpreted without considering symptoms, clinical findings, timing, and exposure risk.

Patients with brain fog, fatigue, palpitations, or neurologic symptoms require a careful clinical evaluation. A negative early test may not exclude Lyme disease, but these symptoms can also occur with many other medical conditions.

Some patients may experience neuropsychiatric symptoms such as irritability or emotional lability. These symptoms are not specific to Lyme disease and should be assessed within the complete clinical picture.

Limitations in Lyme disease testing may contribute to delayed diagnosis, which can increase the risk of persistent symptoms and a more complicated illness course.

For a broader clinical framework, see Persistent Lyme Disease Overview.

Can a Lyme Disease Test Be Wrong?

Yes. Lyme disease tests can produce false-negative results, particularly early in infection before antibodies have reached detectable levels.

False-positive results can also occur. No laboratory result should be interpreted without considering the type of test, the complete two-tier result, symptoms, exposure history, and timing.

A negative Lyme test does not always rule out infection, especially during the first several weeks after a tick bite or other potential exposure.

Why Does a Lyme Disease Test Take So Long?

This question can refer to two different delays: the time required for a laboratory to return the result and the time required for Lyme antibodies to become detectable.

Laboratory turnaround time varies by laboratory and testing method. Some specimens require a second-stage test after the initial screening assay, which may add time before the complete result is reported.

There is also a biological delay. Most Lyme disease tests detect antibodies rather than the bacterium itself. Because antibodies may take several weeks to develop, testing performed soon after infection can be falsely negative even when the laboratory result is returned promptly.

Lyme Disease Test Negative but Have Symptoms

Patients sometimes experience fatigue, brain fog, headaches, joint pain, or neurologic symptoms despite a negative Lyme test.

If testing was performed early, the antibody response may not yet have reached detectable levels. In other cases, symptoms may be related to another medical condition.

When symptoms and exposure history are suggestive, clinicians may consider the timing and type of the initial test, conduct a broader medical evaluation, and repeat testing when appropriate.

What Does an Equivocal Lyme Test Mean?

An equivocal Lyme screening test means the antibody findings are borderline and not clearly positive or negative.

An equivocal first-stage result is not, by itself, a Lyme disease diagnosis. Under two-tier testing, a positive or equivocal initial EIA is followed by the appropriate second-stage assay.

The complete two-tier result should be interpreted together with symptoms, exposure history, and timing of illness. When testing was performed early, repeat testing may sometimes be considered.

What Is the Most Accurate Test for Lyme Disease?

No single Lyme disease test is accurate during every stage of illness.

FDA-cleared standard or modified two-tier antibody testing is the recommended laboratory approach in the United States. These tests perform best after antibodies have developed but may be negative during early infection.

Direct-detection methods, including polymerase chain reaction testing, have limited sensitivity in many routinely tested specimens and do not replace recommended serologic testing in most clinical situations.

The most accurate diagnostic assessment combines appropriate laboratory testing with symptoms, objective clinical findings, exposure history, and timing.

Can Lyme Disease Tests Be False Positive?

Although much attention focuses on false-negative results, false-positive Lyme disease test results may also occur.

Cross-reactive antibodies, previous infection, and testing people with a low likelihood of Lyme disease can complicate interpretation. Antibodies may also remain detectable for months or years after infection and cannot determine whether treatment was successful.

For these reasons, a positive antibody result does not automatically establish that current symptoms are caused by active Lyme disease. Laboratory results must be interpreted within the clinical context.

Clinical Diagnosis of Lyme Disease

Lyme disease diagnosis is based on the combination of exposure risk, symptoms, physical findings, disease stage, and appropriate laboratory testing.

An erythema migrans rash in a patient with plausible tick exposure may be diagnosed clinically without waiting for antibody testing because serology can be negative during early localized disease.

When the rash is absent or the presentation is less specific, laboratory testing and evaluation for alternative diagnoses become increasingly important. A negative early test may need to be interpreted differently from a negative test obtained later in the illness.

Clinical judgment does not mean assuming that every unexplained symptom is Lyme disease. It means interpreting the test within the complete clinical picture rather than treating the laboratory result as an isolated answer.

Testing for Lyme Coinfections

Ticks can transmit more than one pathogen.

Patients evaluated for Lyme disease may also require assessment for infections such as Babesia, anaplasmosis, ehrlichiosis, or other regionally relevant tick-borne diseases.

These infections require separate testing strategies. The appropriate tests depend on the suspected pathogen, symptoms, geographic exposure, and timing of illness.

For a broader overview, see Lyme Disease Coinfections.

Why Lyme Disease Testing Can Be Confusing

Lyme disease testing remains challenging because no single test detects infection reliably during every stage of illness.

Differences in immune response, testing timing, disease stage, assay design, and prior infection may influence results.

Confusion also arises when screening results, second-tier results, and individual antibody bands are interpreted separately instead of as components of a complete testing algorithm.

These challenges are reinforced by broader misconceptions about Lyme disease, particularly the assumption that laboratory testing alone can always confirm or exclude infection.

For a broader discussion, see Lyme Disease Misconceptions.

When Repeat Lyme Testing May Be Helpful

Repeat testing may be appropriate when the initial test was performed early and clinical suspicion remains meaningful.

• Symptoms began recently
• Tick exposure is plausible
• The initial test was obtained during the early antibody window period
• Symptoms or objective findings continue to evolve

In these situations, a clinician may recommend repeat serologic testing after additional time has passed. Repeating the same antibody test indefinitely is generally not useful, and antibody testing should not be used as a test of cure.

Frequently Asked Questions

How accurate are Lyme disease tests?

Lyme disease tests are most accurate after antibodies have developed. Conventional two-tier testing has lower sensitivity during early infection but performs considerably better during disseminated disease.

Can you have Lyme disease and test negative?

Yes. Early in infection, antibodies may not yet be detectable, leading to a false-negative result. The timing and type of test must be considered alongside the clinical presentation.

Why does a Lyme disease test take so long?

Laboratory processing time varies, and a second-stage assay may be required after the initial screening test. Separately, antibodies may take several weeks to become detectable, creating a biological window in which testing can be falsely negative.

What does an equivocal Lyme test mean?

An equivocal screening result is borderline rather than clearly positive or negative. It should be followed by the appropriate second-stage assay and interpreted as part of the complete two-tier result.

What is the most accurate Lyme disease test?

No single test is accurate during every stage of illness. FDA-cleared standard or modified two-tier antibody testing is the recommended laboratory approach in the United States and should be interpreted alongside the clinical presentation.

Can a Lyme disease test be wrong?

Yes. Lyme disease tests may produce false-negative or false-positive results. Timing, disease stage, exposure history, symptoms, and the complete testing algorithm all affect interpretation.

Clinical Takeaway

Lyme disease test accuracy depends heavily on disease stage, timing, and clinical context. Laboratory testing is an important diagnostic tool, but it cannot replace a careful clinical evaluation.

A negative early Lyme disease test does not always exclude infection, while a positive antibody test does not by itself establish active disease. Symptoms, exposure history, clinical findings, and timing remain essential to accurate interpretation.

Related Articles

Post-Treatment Lyme Disease Syndrome
Pediatric Lyme Disease
Autonomic Dysfunction and Lyme Disease

References

1. Moore A, Nelson C, Molins C, Mead P, Schriefer M. Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of Lyme disease, United States. Emerg Infect Dis. 2016;22(7):1169-1177.
2. Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep. 2019;68(32):703.
3. Rodino KG, Theel ES, Pritt BS. Update on North American tick-borne diseases and how to diagnose them. J Clin Microbiol. 2025.
4. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005;18(3):484-509.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention